HealthcareNews

Global Narcolepsy Treatment Market Outlook, Strategies, Challenges,Geography Trends & Growth, Applications and Forecast 2026 by Amneal Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd, Ligand Pharmaceuticals Incorporated, Novartis AG

Global narcolepsy treatment market is expected to grow at a healthy CAGR in the forecast period of 2019-2026. Increase in demand of targeted mode of therapies and high unmet need of treatment are the key factors for growth of this market

This Narcolepsy Treatment report works as a reputable source of information to offer a telescopic view of the existing market trends, situations, opportunities and status. Analysis and discussion of important industry trends, market size, and market share are displayed in this report. Today’s businesses highly choose the market research report such as Narcolepsy Treatment report because it lends a hand with the improved decision making, more revenue generation, prioritize market goals and attain profitable business. This Narcolepsy Treatment market research report offers an actionable market insight with which sustainable and profitable business strategies can be built.

Get Sample Copy Of This [email protected] https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-narcolepsy-treatment-market

Key Market Players:

Few of the major competitors currently working in the global narcolepsy treatment market are Vallon Pharmaceuticals Inc, AVADEL PHARMACEUTICALS, PLC, Jazz Pharmaceuticals plc, BIOPROJET, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd, Ligand Pharmaceuticals Incorporated, Novartis AG, Mylan N.V., Jubilant Life Sciences Ltd, Amneal Pharmaceuticals LLC, Alkem Labs, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd, Zydus Cadila, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc and others

Competitive Analysis:

Global narcolepsy treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global narcolepsy treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Developments in the Market:

  • In January 2018, AVADEL PHARMACEUTICALS, PLC received an Orphan Drug Designation from the FDA for FT 218, a once-nightly formulation of Micropump™ controlled-release (CR) sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients suffering from narcolepsy.
  • In October 2017, Harmony Biosciences, LLC, has acquired the exclusive US right to develop, register and commercialize pitolisant, a selective histamine H3-receptor antagonist from BIOPROJET for the treatment of narcolepsy in adult patients with and without cataplexy. The acquistion of pitolisant, enables the company to accelerate the ability to address unmet needs for patients suffering from sleep and other central nervous system disorders.

Reasons to Purchase this Report

  • Current and future of global narcolepsy treatment market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-narcolepsy-treatment-market

Segmentation: Global Narcolepsy Treatment Market

By Type

  • Type 1 Narcolepsy
  • Type 2 Narcolepsy

By Drugs

  • Selective Histamine H3-Receptor Antagonist
    • Pitolisant
  • Stimulants
    • Modafinil
    • Armodafinil
    • Methylphenidate
    • Amphetamine
  • Serotonin Reuptake Inhibitors
    • Fluoxetine
    • Atomoxetine
    • Others
  • Tricyclic Antidepressants
    • Protriptyline
    • Imipramine
    • Desipramine
    • Others
  • Central Nervous System Depressant
    • Sodium Oxybate
  • Others

By Route of Administration

  • Oral
  • Injectable

By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Inquiry For Customize Report With Discount at :https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-narcolepsy-treatment-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]

Tags

>

Related Articles

Back to top button